New Testimony WITH AUDIO: PsychOdyssey on Involuntary Outpatient Treatment

Cover of testimonyIn 2009 New Jersey passed its “Gregory’s Law“, named for an 11 year old boy murdered by a man with untreated schizophrenia. Although signed by the Governor, the law has not been fully implemented. Only six counties have been able to implement the law so far. Funds for the overall roll-out were held back by the Governor as strove to  balance New Jersey’s budget.

As a result, new legislation has arisen to extend this involuntary commitment treatment law. Assemblyman (and Assembly Deputy Majority Leader) Reed Gusciora has proposed passage of A.2685 to do this. But the legislation goes further. It also seeks to strengthen the provisions of involuntary outpatient treatments by permitting mandate “depot dosing” of anti-psychotic medications. “Depot dosing” is the administration by injection of medication with slow-release molecules which enable medication to be available in a person’s body for 4 to 6 weeks. Depot dosage is favored by some as more convenient, avoiding the daily need to manage medications.

But depot dosage raises other issues, notably side effects. If a patient receiving depot dosage has a nasty side-effect after, say, 2 days, how would that person endure the rest of the month’s period? As a municipal prosecutor, Assemblyman Gusciora may be moved by the laudable aim of helping those who may not be able to help themselves. But many other issues also make forced depot dosing a problematic practice.

To address the issues, today PsychOdyssey’s Tom Pyle testified before the Human Services Committee of the New Jersey State Assembly.

To hear Tom’s testimony, click this link (or cut and paste into Internet Explorer)…

… which will take you to the webpage below: Screen Shot


Then click the link in the red circle to access the audio. (Tom’s testimony begins at 42:30 on the recording clock.) To see the slides to which Tom refers by page number during his oral presentation , click here.

Navigate with others
  • Print
  • Facebook
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • LinkedIn
  • RSS
  • Digg
  • Yahoo! Buzz
This entry was posted in Uncategorized. Bookmark the permalink.